News

The Market Herald – Proteomics receives CE Mark for kidney disease test

Proteomics International Laboratories has secured CE Mark registration for its PromarkerD as a diagnostic medical device.

PromarkerD is a world-first test for predicting the beginning of diabetic kidney disease. CE marking indicates a fitting in with health, safety and environmental protection standards for products sold within the European Economic Area.

Article: Proteomics receives CE Mark for kidney disease test

Subscribe
  • This field is for validation purposes and should be left unchanged.